244 related articles for article (PubMed ID: 26375517)
1. Pathomimetic cancer avatars for live-cell imaging of protease activity.
Ji K; Heyza J; Cavallo-Medved D; Sloane BF
Biochimie; 2016 Mar; 122():68-76. PubMed ID: 26375517
[TBL] [Abstract][Full Text] [Related]
2. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
Chalasani A; Ji K; Sameni M; Mazumder SH; Xu Y; Moin K; Sloane BF
Methods Mol Biol; 2017; 1574():215-225. PubMed ID: 28315254
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
4. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
5. Imaging and quantifying the dynamics of tumor-associated proteolysis.
Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
[TBL] [Abstract][Full Text] [Related]
6. Interrogating the Impact of Protease Activity on Tumor Progression Using 3D Spheroid Models.
Gibson SV; Carter EP; Grose RP
Methods Mol Biol; 2024; 2747():177-188. PubMed ID: 38038941
[TBL] [Abstract][Full Text] [Related]
7. Functional imaging of tumor proteolysis.
Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
[TBL] [Abstract][Full Text] [Related]
8. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
Ramalho SD; Sharma R; White JK; Aggarwal N; Chalasani A; Sameni M; Moin K; Vieira PC; Turro C; Kodanko JJ; Sloane BF
PLoS One; 2015; 10(11):e0142527. PubMed ID: 26562785
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of protease isoforms in the tumor microenvironment.
Liyanage C; Fernando A; Batra J
Cancer Metastasis Rev; 2019 Sep; 38(3):389-415. PubMed ID: 31673830
[TBL] [Abstract][Full Text] [Related]
10. Protease signaling in tumor progression.
Camerer E
Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
[TBL] [Abstract][Full Text] [Related]
11. [Proteases in cancer progression].
Flores-Reséndiz D; Castellanos-Juárez E; Benítez-Bribiesca L
Gac Med Mex; 2009; 145(2):131-42. PubMed ID: 19518020
[TBL] [Abstract][Full Text] [Related]
12. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
[TBL] [Abstract][Full Text] [Related]
13. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
14. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
Doucet A; Overall CM
Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
[TBL] [Abstract][Full Text] [Related]
15. Functional protease profiling for diagnosis of malignant disease.
Findeisen P; Neumaier M
Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
[TBL] [Abstract][Full Text] [Related]
16. Extracellular proteolysis in transgenic mouse models of breast cancer.
Almholt K; Green KA; Juncker-Jensen A; Nielsen BS; Lund LR; Rømer J
J Mammary Gland Biol Neoplasia; 2007 Mar; 12(1):83-97. PubMed ID: 17286208
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS3 restricts cancer invasion in models of early breast cancer progression through enhanced fibronectin degradation.
Gibson SV; Madzharova E; Tan AC; Allen MD; Keller UAD; Louise Jones J; Carter EP; Grose RP
Matrix Biol; 2023 Aug; 121():74-89. PubMed ID: 37336268
[TBL] [Abstract][Full Text] [Related]
18. Circulating Peptidome and Tumor-Resident Proteolysis.
Fan J; Ning B; Lyon CJ; Hu TY
Enzymes; 2017; 42():1-25. PubMed ID: 29054266
[TBL] [Abstract][Full Text] [Related]
19. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.
Whitley MJ; Cardona DM; Lazarides AL; Spasojevic I; Ferrer JM; Cahill J; Lee CL; Snuderl M; Blazer DG; Hwang ES; Greenup RA; Mosca PJ; Mito JK; Cuneo KC; Larrier NA; O'Reilly EK; Riedel RF; Eward WC; Strasfeld DB; Fukumura D; Jain RK; Lee WD; Griffith LG; Bawendi MG; Kirsch DG; Brigman BE
Sci Transl Med; 2016 Jan; 8(320):320ra4. PubMed ID: 26738797
[TBL] [Abstract][Full Text] [Related]
20. Pericellular proteolysis in cancer.
Sevenich L; Joyce JA
Genes Dev; 2014 Nov; 28(21):2331-47. PubMed ID: 25367033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
